COVID-19-specific Anticoagulation

Preferred Label : COVID-19-specific Anticoagulation;

NCIt related terms : COVID-19-specific intermediate- or full-dose anticoagulation;

NCIt definition : Medical prophylactic anticoagulation therapy given to COVID-19 patients to prevent adverse outcomes.;

Alternative definition : ACC/AHA: Intermediate- or full-dose anticoagulation used to prevent VTE complications due to SARS-CoV-2 specifically and not because of documented VTE or another noninfectious indication. Note that this excludes the low-dose prophylactic anticoagulation often given to inpatients for VTE prophylaxis (see below).;

NCI Metathesaurus CUI : CL1905037;

Details

Origin ID

C191450;

UMLS CUI

C5784487;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
concept_is_in_subset
- ACC/AHA COVID-19 Appendix Variables [NCIt concept]
- ACC/AHA Cardiovascular and Noncardiovascular Complications of COVID-19 Terminology [NCIt concept]
- Appendix 8: Pharmacological Therapy Terminology [NCIt concept]
- Therapies for Supportive Care During COVID-19 Infection Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients